National and Kapodistrian University of Athens
Νέοι μοριακοί προγνωστικοί δείκτες για τον καρκίνο του παγκρέατος στον άνθρωπο βασισμένοι στους βιολογικούς μηχανισμούς δράσης των καρκινικών βλαστικών κυττάρων
Abstract
dc:descriptionAIM: Pancreatic cancer has the worst prognosis among all major human tumor groups. A characteristic feature of pancreatic cancer is an extensive fibrotic or desmoplastic reaction surrounding the primary tumor. One of the most selective proteins for tumor stromal fibroblasts is the Fibroblast Activation Protein which is expressed in over 90% of human epithelial carcinomas.. The present study aim to evaluate Fibroblast Activating Protein (FAP) and CD 133 expression in pancreatic cancer and corralate them with the expression of Ki67, P53 and VEGF that are already established prognostic factors in pancreatic cancer. Our aim was to correlate the results in an attempt to elucidate the role of these new molecular markers in pancreatic cancer process.PATIENTS: The study population consisted of patients who underwent curative pancreatic resection during a period of 6 years (2003-2009) at “Laiko” General Hospital of Athens. Paraffin blocks of pancreatic adenocarcinoma and normal adjacent pancreatic tissue were retrieved from the archives of the Department of Pathology. Outcome data were recorded from the notes and the follow up consultations of the patients. Forty six patients (26 men, 20 women) with a mean age 66 (range 53 – 80) were studied. All the tumors were moderately/ poorly differentiated while the disease stage was IIA and IIB in 22 and 24 patients, respectively. The median survival was 11 (4-32) months.METHODS: In the present study we used immunofluorescence and a computer-assisted CLSM method to quantify FAP and CD 133 expression and standard immunohistochemistry to assess Ki67, P53 and VEGF expression in a series of human pancreatic adenocarcinomas.RESULTS: FAP expression in the neoplasm was significantly higher in stage IIB compared to stage IIA (P=0,04). FAP expression was correlated with positive lymph nodes causing worse prognosis in patients with stage disease IIB. FAP expression in the neoplasm was significantly higher in the “highly” expressing Ki67 and VEGF group Multivariate analysis for survival demonstrated the prognostic superiority of FAP over Ki67, P53 and VEGF which is considered the most consistently reproducible molecular marker with prognostic value in resected pancreatic adenocarcinoma, with the effect being independent of Ki67, P53, VEGF expression, disease stage, age and sex. CONCLUSION: As the available systemic therapies for pancreatic adenocarcinoma that target tumor cells have limited clinical benefit, targeting FAP as a therapeutic strategy against cancer is an intriguing concept that needs further investigation.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Patsouras, Dimitrios
- Πατσούρας, Δημήτριος
Subjects
dc:subject × 18- Πρωτείνη ενεργοποίησης ινοβλάστων
- Καρκίνος παγκρέατος
- Αρχέγονα κύτταρα
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας
- Ανοσοϊστοχημεία
- Fibroblast activation protein
- CD133
- Pancreatic cancer
- Stem cells
- Vascular endothelial growth factor
- p53
- Immunohistochemistry
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41439